Lung Cancer Clinical Trials in Dallas, TX

Lung Cancer Clinical Trials in Dallas, TX

View the best 10 lung cancer medical studies in Dallas, Texas. Access promising new therapies by applying to a Dallas-based Lung Cancer clinical trial.

Trials in Dallas, Texas

Here are the top 10 medical studies for lung cancer in Dallas, Texas

Image of University of California Los Angeles Medical Center in Los Angeles, United States.

PRO1184

Chemotherapy

Recruiting1 awardPhase 1 & 2
This trial will test the safety, side effects and effectiveness of a new drug (PRO1184) to treat solid tumor cancers.
Image of Massachusetts General Hospital in Boston, United States.

Pembrolizumab +1 More

Monoclonal Antibodies

Recruiting1 awardPhase 1
This trial will test a drug (CTX-471) alone or with pembrolizumab to treat cancer that has not responded to PD-1/PD-L1 inhibitor drugs. Two parts of the trial will assess different doses.
Image of START Midwest. in Grand Rapids, United States.

COM902

TIGIT Inhibitor

Recruiting1 awardPhase 1
This trial is testing a new cancer drug, COM902, to see if it is safe and works well against cancer.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Hypofractionated Radiation Therapy

Radiation

Recruiting1 awardPhase 2
This trial is testing the safety and effectiveness of a new cancer treatment that involves radiation therapy followed by immunotherapy with atezolizumab.
Image of Carolina BioOncology Institute /ID# 232597 in Huntersville, United States.

ABBV-514 +2 More

Immunotherapy

Recruiting1 awardPhase 1
This trial is testing two experimental drugs, ABBV-514 and Budigalimab, on adults with specific types of cancer. The goal is to find out if these drugs can help treat lung and head/neck cancers by monitoring their effects and side effects.
Image of Exelixis Site #1 in Tucson, United States.

XL092

Recruiting1 awardPhase 1
This trial is testing a new drug called XL092 alone and with other cancer drugs in patients with advanced solid tumors. The goal is to see if these treatments can safely stop or slow tumor growth and help the immune system fight cancer more effectively.
Image of Alaska Oncology and Hematology LLC in Anchorage, United States.

Patritumab Deruxtecan +1 More

Antibody-drug conjugate

Recruiting2 awardsPhase 3
This trial is testing a new drug to see if it's effective and safe for patients with a certain type of lung cancer.
Image of University of Texas Southwestern Medical Center in Dallas, United States.

TVB-2640

Fatty Acid Synthase Inhibitor

Recruiting1 awardPhase 2
This trial will test a new cancer drug, TVB-2640, on patients with a specific type of non-small cell lung cancer.
Image of Medical Oncology Associates in Spokane, United States.

Docetaxel +4 More

Chemotherapy

Recruiting1 awardPhase 2
This trial will measure the effectiveness of a combination of drugs to fight cancer and how safe they are.
Image of Investigational Site Number 8400024 in Tucson, United States.

Docetaxel +1 More

Taxane

Recruiting2 awardsPhase 3
This trial is studying tusamitamab ravtansine to see how well it works compared with docetaxel in treating patients with non-small cell lung cancer that has come back or spread and express CEACAM5.

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.